ArticleEuropean heart journal open2025
Electrocardiographic P-wave indices and onset of atrial fibrillation and histological fibrosis in a general Japanese population: a prospective cohort analysis of the Hisayama Study.
Article in European heart journal open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Atrial Fibrosis Imaging: Correlation of Late Gadolinium Enhancement Magnetic Resonance Imaging With High-Definition Voltage Electroanatomical Mapping Across Different Thresholds.Journal of cardiovascular electrophysiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: P-wave indices (PWIs) are associated with incidence of atrial fibrillation (AF) and extent of left atrial fibrosis. We investigated associations of P-wave duration and P-wave terminal force in V1 (PTFV1) with incidence of AF and extent of atrial fibrosis in a Japanese community. Methods and results: Participants were classified based on P-wave duration in lead II (≥120 and <120 ms) or PTFV1 (≥4000 and <4000 μV*ms). Fibrosis in the left atrial posterior wall was pathologically evaluated in 133 autopsied cases with clinical information. Hazard ratios for AF were estimated using a Cox proportional hazards model. Differences in the extent of left atrial fibrosis between P-wave index categories were tested by analysis of covariance. A total of 2907 community-dwelling individuals aged ≥40 years without prior AF were followed for 10 years. Participants with prolonged P-wave duration or elevated PTFV1 were older and had more cardiovascular risk factors. During follow-up, 140 participants developed AF. Unadjusted incidence rates of AF were significantly higher in participants with P-wave duration ≥120 ms or PTFV1 ≥ 4000 μV*ms than in those with values below these cut-offs (4.6 vs. 10.6, and 4.7 vs. 14.4 per 1000 person-years, respectively; both Conclusion: P-wave duration and PTFV1 are useful indicators for assessing AF risk. Furthermore, prolonged P-wave duration reflects the extent of left atrial fibrosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.